Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Henderson Molly, Chief Financial Officer. Director active across 2 companies, notably UroGen Pharma Ltd.. Cumulatively, 25 reports have been published. Breakdown: 2 buys · 12 sells. Total volume traded: €345k. Activity tracked since 17 May 2021. The latest transaction was disclosed on 7 April 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Henderson Molly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,500 shares@ US$15.85100.0% of flowCommon StockSEC:0001209191-21-033402:0
Canonical exit: 15 Aug 2021 (T+90)
25 of 25 declarations
About Henderson Molly
Henderson Molly is Directeur Financier. She has 25 filings in total. Among the sampled recent filings, they range from 2021-05-18 to 2025-04-08, with buys of EUR 32595 and sells of EUR 312858, and the most common transaction nature is sale.